Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,847.72
1,876.31
1,910.15
1,710.72
1,769.64
1,692.74
1,647.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,847.72
1,876.31
1,910.15
1,710.72
1,769.64
1,692.74
1,647.98
Raw Material Cost
404.24
448.73
463.14
431.27
426.20
446.91
393.14
Purchase of Finished goods
129.79
143.11
126.82
109.16
92.64
120.18
102.64
(Increase) / Decrease In Stocks
-1.88
-62.87
-74.04
-133.02
11.77
-127.55
-66.66
Employee Cost
438.91
432.71
437.54
422.77
393.59
397.52
391.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
648.74
621.13
641.00
599.19
573.52
595.46
588.12
Total Expenditure (Excl Depreciation)
1,619.80
1,582.81
1,594.46
1,429.37
1,497.72
1,432.52
1,408.71
Operating Profit (PBDIT) excl Other Income
227.92
293.50
315.69
281.35
271.92
260.22
239.27
Other Income
25.50
15.50
6.91
6.50
14.19
9.50
16.74
Operating Profit (PBDIT)
253.42
309.00
322.60
287.85
286.11
269.72
256.01
Interest
22.56
23.31
24.23
23.52
24.52
22.26
18.81
Exceptional Items
-24.76
-42.23
0.00
0.00
0.00
0.00
12.87
Gross Profit (PBDT)
206.10
243.46
298.37
264.33
261.59
247.46
250.07
Depreciation
88.59
80.12
76.07
73.77
68.99
70.04
70.51
Profit Before Tax
118.62
161.50
223.72
190.11
191.94
177.78
180.42
Tax
-82.91
29.55
40.01
36.48
35.31
40.08
27.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
200.42
133.79
182.29
154.08
157.29
137.34
152.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
200.42
133.79
182.29
154.08
157.29
137.34
152.28
Share in Profit of Associates
1.11
-1.84
1.42
-0.45
-0.66
0.36
0.86
Minority Interest
-1.17
-1.02
-1.00
-0.75
-0.26
-0.72
-0.27
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
202.70
132.97
184.71
154.38
156.89
138.42
153.41
Equity Capital
39.31
39.31
39.31
39.31
39.31
39.31
39.31
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
10.31
6.77
9.4
7.85
7.98
7.04
7.81
Diluted Earnings per share
10.31
6.76
9.4
7.85
7.98
7.01
7.79
Operating Profit Margin (Excl OI)
12.34%
15.64%
16.53%
16.45%
15.37%
15.37%
14.52%
Gross Profit Margin
11.15%
12.98%
15.62%
15.45%
14.78%
14.62%
15.17%
PAT Margin
10.91%
7.03%
9.62%
8.98%
8.85%
8.13%
9.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 4.41% vs 16.66% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 29.20% vs -11.96% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -16.18% vs 4.56% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -7.99% vs 124.13% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Alembic Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
1,847.72
739.10
1,108.62
150.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,847.72
739.10
1,108.62
150.00%
Raw Material Cost
404.24
102.80
301.44
293.23%
Purchase of Finished goods
129.79
37.50
92.29
246.11%
(Increase) / Decrease In Stocks
-1.88
14.40
-16.28
-113.06%
Employee Cost
438.91
158.50
280.41
176.91%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
648.74
298.30
350.44
117.48%
Total Expenditure (Excl Depreciation)
1,619.80
611.50
1,008.30
164.89%
Operating Profit (PBDIT) excl Other Income
227.92
127.60
100.32
78.62%
Other Income
25.50
77.80
-52.30
-67.22%
Operating Profit (PBDIT)
253.42
205.40
48.02
23.38%
Interest
22.56
10.90
11.66
106.97%
Exceptional Items
-24.76
0.00
-24.76
Gross Profit (PBDT)
206.10
194.50
11.60
5.96%
Depreciation
88.59
50.40
38.19
75.77%
Profit Before Tax
118.62
144.10
-25.48
-17.68%
Tax
-82.91
-89.20
6.29
7.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
200.42
233.30
-32.88
-14.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
200.42
233.30
-32.88
-14.09%
Share in Profit of Associates
1.11
35.70
-34.59
-96.89%
Minority Interest
-1.17
1.10
-2.27
-206.36%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
202.70
267.90
-65.20
-24.34%
Equity Capital
39.31
35.80
3.51
9.80%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
10.31
14.97
-4.66
-31.13%
Diluted Earnings per share
10.31
14.96
-4.65
-31.08%
Operating Profit Margin (Excl OI)
12.34%
17.26%
0.00
-4.92%
Gross Profit Margin
11.15%
26.32%
0.00
-15.17%
PAT Margin
10.91%
31.57%
0.00
-20.66%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,847.72 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -1.52% vs -1.77% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4.41% vs 16.66% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 202.70 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 52.44% vs -28.01% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 29.20% vs -11.96% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 227.92 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -22.34% vs -7.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -16.18% vs 4.56% in Mar 2025
Quarterly - Interest
Interest 22.56 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -3.22% vs -3.80% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -7.99% vs 124.13% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.34%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
